Study Shows Azelastine Nasal Spray May Prevent COVID-19 Spread

A study suggests that the common nasal spray, Azelastine, may help prevent COVID-19 by binding to the coronavirus receptor and reducing virus levels in nasal tissue. Azelastine, approved by the FDA in 1996, is an antihistamine used for allergies.

Scientists are exploring its potential to combat the virus. The spray is available in generic form with a prescription.

Initial findings show promise in repurposing this medication for COVID-19 prevention, as it could limit the virus's access to human cells. This research aims to utilize existing drugs for new purposes in the fight against the pandemic.